Home › Funds › Two Sigma Investments › AMRX
Two Sigma Investments position in AMRX
AMNEAL PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)233.27K sh
Reported value held$4.04M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 392.61K | $2.10M | New |
| Q4 2021 | 274.72K | $1.32M | Reduce |
| Q1 2022 | 118.70K | $495.00K | Reduce |
| Q4 2022 | 578.18K | $1.15M | New |
| Q1 2023 | 191.19K | $265.76K | Reduce |
| Q2 2023 | 461.79K | $1.43M | Add |
| Q3 2023 | 315.76K | $1.33M | Reduce |
| Q4 2023 | 211.17K | $1.28M | Reduce |
| Q1 2024 | 117.67K | $713.06K | Reduce |
| Q2 2024 | 57.79K | $366.95K | Reduce |
| Q3 2024 | 27.25K | $226.68K | Reduce |
| Q1 2025 | 167.70K | $1.41M | New |
| Q1 2025 | 167.70K | $1.41M | New |
| Q2 2025 | 17.75K | $143.56K | Reduce |
| Q2 2025 | 17.75K | $143.56K | Reduce |
| Q3 2025 | 69.53K | $696.03K | Add |
| Q4 2025 | 301.03K | $3.79M | Add |
| Q1 2026 | 282.68K | $3.51M | Reduce |
| Q2 2026 | 233.27K | $4.04M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AMRX
- BlackRock Inc 26.56M sh · $459.79M · Q2 2026
- Vanguard Group 17.91M sh · $225.64M · Q4 2025
- Geode Capital Management 5.14M sh · $88.98M · Q2 2026
- Morgan Stanley 4.11M sh · $71.14M · Q2 2026
- Invesco Ltd 3.50M sh · $60.62M · Q2 2026
- Goldman Sachs Group 3.01M sh · $52.17M · Q2 2026
- Charles Schwab Investment Management 2.15M sh · $37.17M · Q2 2026
- Northern Trust Corp 1.91M sh · $33.15M · Q2 2026
- BNY Mellon 1.02M sh · $17.57M · Q2 2026
- Principal Global Investors 991.82K sh · $17.17M · Q2 2026
- Fidelity Management & Research (FMR) 825.12K sh · $14.28M · Q2 2026
- JPMorgan Chase & Co 795.00K sh · $13.85M · Q2 2026